Broad Institute Receives $650 Million Gift for Psychiatric Research
the Psychiatry Advisor take:
The largest private donation for psychiatric research — $650 million — has been given to the Cambridge, Massachusetts-based Broad Institute by philanthropist and businessman Ted Stanley.
Stanley, who made his fortune heading a company that markets and sells collectibles, was moved to support mental health research after his son, Jonathan, was diagnosed with bipolar disorder in college. He was treated with lithium and is now a successful lawyer.
“Essentially, it gave him the ability to have a normal life with a normal functioning brain,” Stanley told The Boston Globe. “If I had had the same downfall at the same age that he had, I would have had my life ruined . . . because in between when I was that age and he was that age, someone had discovered that lithium makes people well when they have that illness.”
The Stanley Medical Research Institute had previously given the Broad a $175 million gift. The $650 million gift will not be given at once, but in annual payments with more after Stanley’s death.
Broad researchers contributed to the recent publication in Nature of the largest genomic study of schizophrenia. That study could lead to new treatments that target the molecular causes of the disease.
Philanthropist Gives $650 Million Gift for Psychiatric Research
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- ADHD Medications Compared for Efficacy, Tolerability in Children and Adults
- Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Low-Dose Ketamine Benefits Cognitive Function in Treatment-Resistant Depression
- Mobile-Based Application Shows Benefits for Young Patients With Schizophrenia
- Healthcare Community Should Favor More Restrictive Alcohol Policies
- How to Respond to a Patient's Request for Prayer: A Clinician's Dilemma
- Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data